(1)
Full
License. The Board shall determine whether an applicant is
qualified, competent and of good moral character to hold a full active license to
practice medicine. In order to qualify for a full active medical license as that
term is defined in M.G.L. c. 112, § 2, and
243 CMR 2.00, a graduate of an
international medical school or a graduate of a Fifth Pathway program shall meet
the prerequisites for licensure as set forth in
243
CMR 2.02(1), except as
otherwise provided, and the standards in 243 CMR 2.03(1)(a) through (e), in
addition to the standards imposed by M.G.L. c. 112, § 2, and
243 CMR 2.00:
(a)
Medical Education.
Each applicant for a full license shall have received a degree of doctor of
medicine, or its equivalent from a program determined by the Board to be
substantially equivalent to the medical school programs accredited by the LCME,
or the degree of doctor of osteopathy or its equivalent from a program determined
by the Board to be substantially equivalent to the osteopathic school programs
accredited by the AOA.
(b)
Substantial Equivalency of Medical Education. In order
to be considered substantially equivalent, such medical education shall include:
1. Two academic years of basic science study,
including:
a. gross anatomy;
b. biochemistry;
c. pathology;
d. physiology;
e. microbiology;
f. immunology; and
g. pharmacology.
2. Two academic years of clinical study
including:
a. internal medicine;
b. surgery;
c. pediatrics;
d. obstetrics and gynecology;
e. public health and preventive medicine;
and
f. psychiatry.
3.
Clinical
Training. The Board must also be satisfied that all clinical
training is substantially equivalent to the minimum standards required of United
States medical school graduates. The applicant shall submit documentation
satisfactory to the Board that all clinical study was done:
a. Under the direct control and approval of the
medical school and under on-site supervision and evaluation by the faculty of the
medical school in which the applicant was enrolled at the time of study, and in
hospitals which have, in the Board's opinion, programs equivalent to ACGME or AOA
approved programs in the area of clinical study;
b. Clinical study done in the United States
shall be in hospitals which have ACGME or AOA approved programs in the area of
the clinical study. Clinical study done in Canada shall be in hospitals which
have accredited Canadian postgraduate medical training programs. Supervising
clinical faculty shall be physicians who are fully licensed by the jurisdiction
where such study is done.
4. Board staff may request additional
documentation during the licensure process which may include, but is not limited
to:
a. A formal evaluation by the faculty of the
clinical clerkship;
b. A formal
written agreement between the medical school and the place of clinical study;
or
c. A course catalog.
5. The Board, in its discretion, may
determine that any college of medicine that had its accreditation withdrawn by a
national or regional accreditation organization; or had its authorization,
certification or licensure revoked or withdrawn by a national governmental
supervisory agency; or issued a medical degree based entirely on coursework via
the Internet or via online programs, is inconsistent with quality medical
education. Such a program of education will not be an approved college of
medicine for the purpose of fulfilling the medical education requirement of
243
CMR 2.02(1).
(c)
ECFMG
Certificate. A candidate for licensure shall possess an ECFMG
certificate which is valid on its face and valid as of the date of licensure.
Pursuant to M.G.L. c. 112, § 2, an ECFMG certificate is not required for
graduates of Fifth Pathway programs.
(d)
Postgraduate Medical
Education. Each applicant for a full license must have
satisfactorily completed at least two years of post graduate medical training in
an ACGME or AOA approved or accredited Canadian program. Effective January 1,
2014, each applicant for a full license must have satisfactorily completed at
least three years of post graduate medical training in an ACGME or AOA approved
or accredited Canadian program. However, in the case of subspecialty clinical
fellowship programs, the Board may accept post graduate training in a hospital
that has an ACGME or AOA or accredited Canadian post graduate medical training
program in the parent specialty.
1. The Board
may, in its discretion, accept teaching experience as post graduate training,
when it consists of a faculty appointment at or above the assistant professor
level at a medical school accredited by the LCME, if the majority of the teaching
experience documented is clinical teaching with supporting evidence of either
special honors or awards which the applicant has achieved or articles the
applicant has published in reputable medical journals or medical textbooks. With
the same supporting evidence, the Board may accept teaching experience at the
instructor level with the following consideration: There is a presumption against
accepting instructor level teaching experience when combined with a waiver
request for any other section of 243 CMR 2.03. The Board, in its discretion, may
overcome this presumption only in extraordinary circumstances.
2. In its discretion, the Board may consider
for licensure an applicant who has completed two years of ACGME or AOA approved
or accredited Canadian postgraduate training and who:
a. Holds a current, active, unrestricted
medical license in another state; and
b. Demonstrates continuous clinical activity;
and
c. Is board certified by either
ABMS or AOA.
(e)
Waiver of Substantial
Equivalency. In situations where an applicant cannot comply with 243
CMR 2.03 requiring substantial equivalency of medical school education, the
applicant must submit a waiver request pursuant to 243 CMR 2.03. In order for the
Board to grant such a waiver request, the Board must determine that the licensure
of this applicant would not impair the public health, safety and welfare, and
that the applicant meets the standards of M.G.L. c. 112, §§ 2 through
9B. It is the applicant's responsibility to demonstrate he or she is qualified
under these standards. The assessment and determination of the applicant's
equivalency of complete medical education will include, but not be limited to,
the following factors:
1. Applicant must be
qualified, competent and of good moral character;
2. Applicant must have held an unlimited,
unrestricted medical license in a state or states for a period of two years. Any
time spent by the applicant in postgraduate training or clinical fellowship shall
not be included in the calculation of this two-year requirement;
3. Applicant must have satisfactorily completed
postgraduate training in an ACGME or AOA approved postgraduate training
program;
4. Applicant must have
American Specialty Board certification by the ABMS or AOA; and
5. Applicant must have successfully completed
all three Steps of the USMLE or all three Levels of the COMLEX examination within
a seven year period. The seven-year period begins on passing the first Step or
Level of the examination.
(f)
Waiver of Any 243 CMR 2.03
Requirement. An applicant for a full license pursuant to 243 CMR
2.03 may make a written request to the Board for a waiver of any requirement of
243 CMR 2.03. The Board, in its discretion, may grant the waiver as requested, or
with modifications thereof, upon finding:
a. The
applicant meets the standards of M.G.L. c. 112, §§ 2 through 9B;
and
b. Such a waiver would promote
the public health, safety or welfare.
(2)
Limited License for Graduates
of an International Medical School or Fifth Pathway Program. The
Board shall determine whether an applicant is qualified, competent and of good
moral character to hold a limited license to practice medicine. In order to
qualify for a limited license as that term is defined in M.G.L. c. 112, § 9,
and
243 CMR 2.00, a graduate of an
international medical school or a graduate of a Fifth Pathway program shall meet
the prerequisites in
243
CMR 2.02(7) and the following
standards:
(a)
Postgraduate
Training. The applicant shall be enrolled in a post graduate medical
education program in hospitals or equivalent institutions within the Commonwealth
of Massachusetts. All such training shall be done in ACGME or RRC or AOA approved
programs, or in a sub specialty clinical fellowship program in a hospital that
has an ACGME or RRC or AOA approved program in the parent specialty.
(b)
Refugee
Applicants. In the case of a refugee applicant, the Board, in its
discretion, may accept as post graduate training, enrollment in an individualized
training program in a hospital or other similar institution for a period of time
between one and two years duration under the direct supervision and control of a
fully licensed physician on the staff of such institution. An applicant seeking
approval for such an alternative program under 243 CMR 2.03(2) shall submit a
written proposal to the Board. The Board may adopt guidelines, including a list
of criteria for approval of such programs. All training programs must have prior
approval of the Board.
(c)
Request to Approve Individualized Training Program. The
Board may appoint an Advisory Panel on Refugee Physicians. The Board may request
such an Advisory Panel or member(s) thereof to review the applications of refugee
physicians and make recommendations to the Board regarding said applications,
including requests for approval of individualized training programs under 243 CMR
2.03(2). Any such recommendations are advisory and are not binding on the Board
of Registration in Medicine. An applicant who wishes to have an individualized
training program approved under 243 CMR 2.03(2)(a)2. shall submit documentation
that he or she has made a good faith effort to be accepted in an ACGME or AOA or
RRC approved program, and has been unsuccessful in that effort. For the purposes
of 243 CMR 2.03(2), the term "refugee" shall mean a person who:
1. Has applied and is being considered for, or
has received asylum in the United States under the Political Asylum Code, 8 CFR
208;
2. Was admitted to the United
States on a humanitarian visa or on the parole authority of the Attorney General
of the United States ( 8 U.S.C. 1142(D)(5)); or
3. Any person outside his or her country of
nationality who is unable or unwilling to return to such country, and is unable
or unwilling to avail himself or herself of the protection of that country
because of persecution or a well founded fear of persecution on account of race,
religion, nationality, membership in a particular social group, or political
opinion.
(d)
Standards. The applicant shall meet the standards listed
in 243 CMR 2.03(1)(a) through (c).
(e)
Waiver of Substantial
Equivalency. In situations where a limited license applicant cannot
comply with 243 CMR 2.03 requiring substantial equivalency of medical school
education, the applicant must submit a waiver request pursuant to 243 CMR 2.03.
In order for the Board to grant such a waiver request, the Board must determine
that the licensure of this applicant would not impair the public health, safety
and welfare, and that the applicant meets the standards of M.G.L. c. 112,
§§ 2 through 9B. It is the applicant's responsibility to demonstrate he
or she is qualified under these standards. The assessment and determination of
the applicant's equivalency of complete medical education and eligibility for
training in Massachusetts may include, but not be limited to, the following
factors:
1. Applicant must be qualified,
competent and of good moral character;
2. Applicant must hold an unlimited,
unrestricted medical license in another state or states;
3. Applicant must have held an unlimited,
unrestricted medical license in a state or states for a period of two years. Any
time spent by the applicant in postgraduate training or clinical fellowship shall
not be included in the calculation of this two-year requirement;
4. Applicant must have successfully completed
Steps 1 and 2 of the USMLE or Levels 1 and 2 of the COMLEX examination;
5. Quality of basic science
education;
6. Quality of clinical
clerkship experience (evaluations required);
7. Other distinctions; honors, awards,
publications;
8. Nature and quality
of anticipated training program, including degree and quality of supervision;
and
9. Personal interview with the
applicant.
(3)
Temporary License for a Graduate of an International Medical School
or Fifth Pathway Program. The Board shall determine whether an
applicant is qualified, competent and of good moral character, to hold a
temporary license to practice medicine. In order to qualify for a temporary
license, as that term is defined in M.G.L. c. 112, § 9B, and
243 CMR 2.00, a graduate of an
international medical school or a graduate of a Fifth Pathway program shall meet
the following standards:
(a) The applicant shall
meet the standards listed in 243 CMR 2.03(1).
(b) At the discretion of the Board, an
applicant may be issued a temporary license in the following circumstance:
1. If the applicant is a visiting physician,
with a license to practice in another state or territory or in the District of
Columbia or in another country and has a temporary faculty appointment certified
by the Dean of the medical school in the Commonwealth for purposes of medical
education in an accredited hospital associated with the medical school;
and
2. Has demonstrated outstanding
expertise in a medical specialty. The Board shall take the following factors into
consideration when evaluating such an applicant:
a. The quality of medical education and
clinical training;
b. Teaching
experience;
c. Board
certification;
d. Special honors or
awards;
e. Articles published in
reputable medical journals and medical textbooks; and
f. Perfection of a medical technique which is
unique and beneficial for the alleviation or cure of disease.
(c) A temporary license
expires 12 months from the issue date, except as otherwise provided. A subsequent
temporary license may be issued at the discretion of the Board.
(4)
Waiver of a 243 CMR
2.03 Requirement. An applicant may make a written request to the
Board for a waiver of the provisions of any of the requirements in 243 CMR 2.03.
The Board, after determining that the applicant meets the standards of M.G.L. c.
112, §§ 2 through 9B; and that such a waiver would not harm the public
health, safety or welfare, may grant the waiver as requested or with
modifications thereof.